Transcutaneous Auricular Vagus Nerve Stimulation Treatment for Erythematotelangiectatic Rosacea

What is the efficacy profile of transcutaneous auricular vagus nerve stimulation (taVNS) for patients with erythematotelangiectatic rosacea (ETR)?In this single-center, randomized, double-blind, sham-controlled device clinical trial of 72 patients with ETR, taVNS achieved clinically significant improvements of facial erythema, flushing, anxiety, depression, sleep disorders, migraine, and fatigue for patients with ETR compared with a sham stimulation.The results of this randomized clinical trial support taVNS being an efficacious novel treatment for treating ETR.

Corresponding Authors: Fei Hao, PhD, Department of Dermatology, The Third Affiliated Hospital of Chongqing Medical University, No. 1 Shuanghu Branch Rd, Huixing Sub-district, Yubei District, Chongqing, Chongqing 400039, China (hf1962@126.com); and Jingming Hou, PhD, Department of Rehabilitation, Southwest Hospital, Third Military Medical University (Army Medical University), Chongqing, China (jingminghou@tmmu.edu.cn).

Link to the article in your story

We encourage you to link out to this article in your story using the link below. It includes an access token that will give free access to the article for your readers up to one year after publication. (The link will be live after the article publishes and embargo is lifted.)

Please see the article for additional information, including full author list, author contributions and affiliations, conflict of interest and financial disclosures, and funding and support.

Need more information? Contact us.